NCM · Biotechnology

CollPlant Biotechnologies Ltd. (CLGN) Stock

$3.51 -11.59% NCM: CLGN Healthcare

Valuation

MetricValue
Price$3.51
Market Cap$4.55M
P/E Ratio-0.37
P/B Ratio1.69
P/S Ratio14.11
EPS (TTM)$-0.94
52-Week High$26.80
52-Week Low$2.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-215.58%
ROA-173.86%
ROCE-263.32%
Gross Margin-600.00%
Operating Margin-550.00%
Net Margin-4.85%
Debt/Equity0.90
Current Ratio2.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.0M$0$11.0M$1.0M$2.0M
Operating Profit$0$-17.0M$-8.0M$-17.0M$-11.0M
Net Profit$0$-17.0M$-7.0M$-17.0M$-11.0M
EPS$0.34$-15.20$-6.20$-14.50$-9.40
Op Margin0.4%-5718.1%-68.5%-3349.7%-484.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$51.0M$38.0M$34.0M$19.0M$11.0M
Total Liabilities$6.0M$5.0M$6.0M$5.0M$5.0M
Cash$13.0M$30.0M$27.0M$12.0M$6.0M
Borrowings$4.0M$3.0M$3.0M$3.0M$3.0M

Latest News

CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares MT Newswires · Jul 9, 2026 COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT PR Newswire · Jun 30, 2026 COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.0M$-14.0M$-3.0M$-14.0M$-9.0M
Investing Cash Flow$-33.0M$28.0M$-2.0M$-1.0M$0
Financing Cash Flow$39.0M$2.0M$1.0M$0$0
Net Cash Flow$10.0M$16.0M$-3.0M$-15.0M$-6.0M
Free Cash Flow$1.0M$-15.0M$-4.0M$-15.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.36
FCF Yield-260.81%
Quick Ratio1.35
Interest Coverage-82.70
Return 1Y-79.83%
Return 3Y-94.79%
Return 5Y-98.11%

Ownership

Insiders Held20.50%
Institutions Held9.18%
Institutions Float Held11.54%
Institutional HolderSharesReport Date
Villere St. Denis J. & Co. LLC607,3002026-03-31
Pinnacle Associates, Ltd.550,2292026-03-31
Brown Advisory Inc.118,7312026-03-31
Armistice Capital, LLC64,0002026-03-31
Pathstone Holdings, LLC57,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd. is led by CEO Yehiel Tal, employs 57 people, headquartered in IL, publicly traded since 2018.

CollPlant Biotechnologies Ltd. (CLGN) stock trades at $3.51 with a market capitalization of $4.55M. The stock is valued at a price-to-earnings (P/E) ratio of -0.37, price-to-book of 1.69, price-to-sales of 14.11. Over the past 52 weeks the stock has ranged between $2.64 and $26.80, and currently trades 86.9% below its 52-week high.

On profitability, CollPlant Biotechnologies Ltd. generates a return on equity (ROE) of -215.58%, return on capital employed of -263.32%, an operating margin of -550.00%, a net profit margin of -4.85%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides